Search Results Search Sort by RelevanceMost Recent Letter to the Editor Jul 2020 Response to “How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?” A Deliberate Public Policy Plus Naivety at Best Alain Braillon, MD, PhD Do the WHO and health professionals simply fail to do their job adequately? AMA J Ethics. 2020;22(7):E639-642. doi: 10.1001/amajethics.2020.639. Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643. Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602. Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603. Case and Commentary Aug 2022 When Is Iatrogenic Harm Negligent? Ramya Sampath All harm resulting from negligence is iatrogenic, but not all iatrogenic injury is negligent. AMA J Ethics. 2022;24(8):E735-739. doi: 10.1001/amajethics.2022.735. State of the Art and Science Aug 2022 How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients Antonio D. Garcia and Ximena Lopez, MD Transgender people commonly experience discrimination from clinicians, which directly contributes to worse mental and physical health outcomes. AMA J Ethics. 2022;24(8):E753-761. doi: 10.1001/amajethics.2022.753. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Letter to the Editor Jul 2020 Response to “How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?” A Deliberate Public Policy Plus Naivety at Best Alain Braillon, MD, PhD Do the WHO and health professionals simply fail to do their job adequately? AMA J Ethics. 2020;22(7):E639-642. doi: 10.1001/amajethics.2020.639.
Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643.
Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602.
Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603.
Case and Commentary Aug 2022 When Is Iatrogenic Harm Negligent? Ramya Sampath All harm resulting from negligence is iatrogenic, but not all iatrogenic injury is negligent. AMA J Ethics. 2022;24(8):E735-739. doi: 10.1001/amajethics.2022.735.
State of the Art and Science Aug 2022 How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients Antonio D. Garcia and Ximena Lopez, MD Transgender people commonly experience discrimination from clinicians, which directly contributes to worse mental and physical health outcomes. AMA J Ethics. 2022;24(8):E753-761. doi: 10.1001/amajethics.2022.753.